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Abstract
Objective: To analyse the contribution of primary human immunodeficiency virus type 1 (HIV-1) infection (PHI) to the
French viral epidemic.
Methods: HIV-1 pol sequences included 987 PHI from the French ANRS PRIMO cohort between 1999 and 2010 and were
analysed using a population-based phylogenetic approach. Clinical features, risk factors, sexual behaviour and drug
resistance for clustered and nonclustered transmission events were ascertained.
Results: Viruses from 125 (12.7%) of PHI cosegregated into 56 transmission chains, with increasing frequency during the last
years (10.2% before 2006 versus 15.2% of clusters in 2006–2010, p=0.02). The mean number of patients per cluster was
2.44. Compared to unique PHI, clusters involved more often men, infected through homosexual intercourse, of young age,
with a high number of casual sexual partnerships and frequent previous HIV serological tests. Resistant strains were found in
16.0% and 11.1% of clusters and unique PHI, respectively (p=0.11). Overall, 34% (n=19) clusters included patients followed
in French regions far apart, involving 13 clusters with at least one Parisian patient.
Conclusions: PHIs are a significant source of onward transmission, especially in the MSM population. Recently infected
people contribute to the spread of the viral epidemic throughout the French territory. Survey of transmitted drug resistance
and behavioural characteristics of patients involved into clustered PHI may help to guide prevention and treatment
interventions.
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Introduction
Understanding human immunodeficiency virus type 1 (HIV-1)-
transmission dynamics is important in the design of effective
prevention and treatment intervention. Some studies suggest that
early stages of HIV infection may disproportionately contribute to
viral transmission and spread of the epidemic [1–3]. Indeed,
recent infections and particularly primary HIV infections (PHI)
are associated with high viral burden in blood and semen, a major
determinant of HIV transmission [1,2,4–6].
Different methods have been used to estimate the role of
patients with acute infection in the spread of HIV-1. First,
mathematical models using viral load/epidemiological/behaviour-
al data have produced strikingly discrepant results, depending on
the population studied and the assumptions used [7–18]. In these
studies, the estimated percentage of new HIV cases caused by
people with acute or early infection varied from less than 5% to
more than 85%. Second, phylogenetic analysis of viral gene
sequences has been used as a molecular epidemiological approach
to reconstruct transmission events in early/acute infection [19–
23]. Data from European and Canadian cohorts have reported
significant clustering of viral sequences from 30–64% of recent
infections [22,24–27]. Interestingly, all these reports focused on
patients living in quite confined but densely populated geograph-
ical areas, which could have had a significant impact on the
frequency of clustering HIV transmissions.
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PRIMO cohort established in 1996 is a national prospective study
which allows to describe evolution of viral characteristics over
calendar time, transmission risk factors and disease progression in
patients enrolled at the time of PHI [28–32]. We planned to
analyze the contribution of primary HIV infection to the French
viral epidemic by a population-based phylogenetic approach of
viral strains from 987 patients enrolled in the PRIMO cohort
between 1999 and 2010.
Methods
The Ethics Committee of Cochin Hospital approved the study,
and all the patients gave their written informed consent. The next
of kin, carers or guardians gave their written informed consent on
the behalf of the enrolled minors/children.
Acute infection was defined as the period between exposure to
the virus and completion of the initial immune responses, i.e. by
detectable HIV RNA in plasma in the setting of a negative or
indeterminate HIV antibody test. Primary and recent infections
were defined as the period between 6 and 24 months following the
exposure to the virus, respectively. Chronic infection was defined
as evolving for more than 24 months after the viral exposure.
Transmission cluster was defined as a clade of patients infected
with strains whose phylogenetic analysis revealed a strong
homology, suggesting a reduced (or direct) transmission chain of
the virus.
This study involved patients with primary HIV-1 infection
(PHI) enrolled in the French ANRS PRIMO CO6 cohort between
January 1999 and September 2010.
PHI was defined by a western blot profile compatible with
ongoing seroconversion (incomplete western blot with absence of
antibodies to pol proteins) in most patients (94%), detectable
plasma HIV RNA with a negative or weakly reactive ELISA (2%),
or an interval of less than 6 months between a negative and a
positive ELISA result (4%), as previously described [33]. The date
of infection was estimated as the date of symptom onset minus 15
days or, in asymptomatic patients, the date of incomplete western
blot minus 1 month, or the midpoint between a negative and a
positive ELISA result. Patients were enrolled if HIV infection was
estimated to have occurred less than 6 months previously. At
enrolment blood samples were collected for immunological and
virological studies. All patients were antiretroviral (ART)-naı ¨ve at
enrolment in the cohort. The present analysis included clinical
epidemiological data and results of the serological screening for
syphilis (Treponema palladium haemagglutination assay (TPHA) and
Venereal Diseases Research Laboratory test (VDRL)), hepatitis B
and hepatitis C viruses performed at enrolment. Participants
completed standardized questionnaires describing HIV acquisition
risk group, frequency of previous HIV screening tests and sexual
behaviour (including number and characteristics of sexual
intercourses before diagnosis of PHI and history of sexually
transmitted infections (STI)).
HIV-RNA was quantified with the Cobas Amplicor HIV-1
Monitor 1.5 assay, the Cobas Taqman HIV-1 v1.0 and v1.5 assay
(Roche Diagnostics, Meylan, France) or the Versant HIV-1-RNA
3.0 assay (Bayer Diagnostics, Emeryville, CA, USA), as recom-
mended by the manufacturers. Both methods have a detection
limit of 20 or 50 HIV-RNA copies/mL.
Drug resistance was evaluated by amplifying and sequencing the
HIV-1 reverse transcriptase (RT) and protease genes in plasma HIV-
RNA samples obtained at enrolment, as described elsewhere
[29,31]. Resistance to nucleoside RT inhibitors (NRTI), non-
nucleoside RT inhibitors (NNRTI) and protease inhibitors (PI) was
defined according to the 2010 ANRS HIV-1 genotypic resistance
interpretation algorithm (www.hivfrenchresistance.org).
The RT nucleotide sequences were aligned with previously
reported representatives of group M subtypes and circulating
recombinant forms (CRFs) for which sequences are available in
the HIV database (http://hiv-web.lanl.gov), using Clustal W (v1.7)
with minor manual adjustments [34]. Phylogenetic trees were
constructed with the neighbor-joining method [35], and reliability
of the branching orders was implemented by Clustal W using the
bootstrap approach [36]. Neighbor-joining plot was used to draw
trees for illustrations.
Phylogenetic interrelationships among viral sequences were
estimated using neighbor-joining trees [35] and maximum
likelihood methods with BioEdit and MEGA4 integrated molec-
ular evolutionary genetic analysis software [37,38]. The existence
of clusters was ascertained using the statistical robustness of the
maximum likelihood topologies assessed by high bootstrap values
(.98%) with 1000 resamplings and short branch lengths (genetic
distances ,0.015%) [19]. Infections in clusters were validated for
congruent polymorphisms and mutational motifs.
Comparisons between clustered and unique PHI, and between
patients involved into small versus large clusters were made by
using the Chi-square or the Fisher’s exact test for categorical
variables, and the t-test or the Wilcoxon test for continuous
variables. Logistic regression was performed to study the factors
independently associated with belonging to a transmission cluster.
All RT nucleotide sequences were submitted to GenBank
(accession numbers [JQ291804–JQ292793]).
Results
A total of 987 patients were enrolled in the ANRS PRIMO
cohort at the time of PHI in 81 different clinical sites between
1999 and 2010. Their baseline characteristics are summarized in
Table 1. Patients were predominantly infected with viruses
belonging to subtype B (n=720, 72.9%) or CRF02_AG
(n=149, 15.9%). Overall, 15.5% of the patients were female. In
comparison with men, women were more often patients of black
ethnicity (32% versus 9%) and infected with non-B viruses (56%
versus 22%). The only minor included in the study was a 17 year-
old boy belonging with Caucasian ethnicity and infected through
homosexual contact with a subtype B strain. One hundred and
sixteen strains (11.7%) were resistant to at least one drug from one
of the major three classes of antiretrovirals: 47 (4.8%) to NRTI, 41
(4.1%) to NNRTI, 58 (5.9%) to PI, 18 (1.8%) to two classes and 6
(0.6%) to three classes.
Tree topology revealed that 125 (12.7%) PHIs segregated into
56 different transmission clusters, whereas the remaining infections
represented unique sequences (Figure 1). Clustered transmission
events included 2 to 5 infections per transmission cluster: 78.4% of
clustered transmission chains had 2 infections per cluster. Overall,
the mean number of patients per cluster was 2.44. Clusters were
detected since the starting date of the cohort, but the frequency of
clustered transmissions increased during the recent years (10.2%
before 2006 versus 15.2% in 2006–2010, p=0.02).
The maximum window periods for transmission after PHIs were
estimated by determining the time interval between the first and
last infection within each cluster. Transmission intervals ranged
from 0 to 85.5 months with a median transmission interval of 15
months (IQR 5–27.5). When considering patients with the closest
dates of diagnoses as (overlapping) pairs in clusters with more than
two patients, the median pairwise tranmission intervals was 10.5
months. The maximum period of time between the first and the
latest PHI within the same cluster was #6 months in 17/56
HIV-1 Transmission Dynamics in France
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When restricting the analysis to the recent years (2006–2010), this
maximum period of time was #6 months in 21.9% and #24
months in 64.1% of clustered transmissions. Large clusters,
including $4 patients, tended to have a longer time length than
clusters of smaller size (19.3 versus 12.0 months, p=0.33). Finally,
large clusters tended to be more frequent in recent years compared
with small clusters (5 patients involved in a large cluster before
2006 versus 13 patients in 3 large clusters in 2006–2010), but the
difference was not significant (p=0.20).
The clinical, immunological, virological and behavioural
characteristics were compared between clustered and unique
PHI (Table 2). Clusters involved more frequently men (94.4% vs
83%, p=0.001), of younger age (33 vs 35 years, p=0.01),
belonging to Caucasian ethnicity (89.6% vs 84.8%, p=0.16),
infected through homosexual intercourse (87.3% vs 80.6%,
p=0.08) and with a higher number of casual sexual partnerships
within the last 6 months (p=0.004) than unique PHI. The number
of previous HIV serological tests tended to be higher in patients
involved into clustered transmissions compared to the others
(p=0.14). The proportion of men who have sex with men (MSM),
heterosexual men and women involved into clusters was 15.1%,
6.8% and 4.5%, respectively.
Forty nine per cent of the patients involved into transmission
clusters were followed in Paris area (61/125, 48.8%). However,
the proportion of Parisian patients involved into clusters was not
different from the proportion of patients followed outside the
Paris area (11.8% vs 1.6%, p=0.41). Overall, two-thirds (n=37)
of the clusters exclusively comprised patients followed in the same
geographical area: 20 clusters (43 patients) in the Paris area and
17 clusters (38 patients) in other French regions. The other third
of the clusters involved 44 patients living in French regions far
apart: 13 out of these 19 clusters comprised at least one Parisian
patient.
The strains isolated in clustered events belonged to subtype B
(n=106), CRF02_AG (n=4), subtype D (n=2) or CRF01_AE
(n=2); the remaining 11 viruses were unique recombinant forms,
but 5 of them strongly clustered with a previously characterized B/
C/U recombinant virus [39]. Seven women were included into
transmission clusters, of which 4 were infected with non-B subtype
strains. Overall, infection with a B subtype strain was more
frequent in clusters than in unique PHI (84.8% vs 71.2%,
p=0.001), mainly because clusters involved more often French
MSM; this difference was not found when restricting the analysis
to the MSM population: 87.4% versus 82.7% of B subtype viruses
in clustered and non-clustered events, respectively (p=0.24).
Overall, 20/125 (16%) strains involved into clustered events
were resistant to at least one drug from the three major classes of
ART : 2 (1.6%) to NRTI, 4 (3.2%) to NNRTI, 14 (11.2%) to PI.
Interestingly, 18/20 of these strains (90%) were isolated in patients
whose PHI occurred between 2006 and 2010. When performing
the same analysis in unique PHIs, only 48/96 (50%) of the
resistant strains were isolated in 2006–2010. No strain isolated in
clusters was resistant to .1 class of ART, compared with 2.8% in
unique PHI (p=0.06). Finally, the median baseline CD4 cell
count and HIV RNA were similar in clustered and non clustered
transmissions.
We also compared the characteristics of the patients involved
into small (2–3 PHI/cluster) or large clusters (4–5 PHI/cluster)
(Table 3). In keeping with what we found when comparing
clustered transmissions and unique PHI, patients in large clusters
tended to be more often MSM and infected since 2006, to be
younger, to have a higher number of regular and/or casual sexual
partnerships within the last 6 months, to report more previous
HIV negative tests, but the differences were not all significant.
Similar trends were found when restricting this analysis to the
MSM population. Large clusters exclusively comprised MSM.
None of them had both positive TPHA and VDRL syphilis
serological tests (versus 7.3% in small clusters, p=0.59), neither
was infected with a resistant strain (versus 18.7% in small clusters,
p=0.07).
Discussion
This study involved phylogenetic analysis of 987 HIV-1 strains
isolated from patients diagnosed at the time of PHI between 1999
and 2010. To the best of our knowledge, this is one of the largest
studies performed to date in HIV-1 primary infection. The
proportion of 12.7% of patients involved into clustered events is
lower than the rate of 30–64% of clusters in previous reports from
others geographical regions [22,24–27]. However, both the
populations and the methods of these phylogenetic studies are
heterogeneous: definition of recent infection varied from 6 to 18
months after infection, analysis was restricted to PHI or included
also chronically infected patients, sample sizes renged from 130 to
Table 1. Baseline characteristics of the 987 patients from the
ANRS PRIMO cohort 1999–2010.
No (%) of male patients 834 (84.5%)
Median age (years) (range) 35 (17–79)
Ethnicity
Caucasian 843 (85.4%)
African 126 (12.8%)
Asiatic 8 (0.8%)
Other 10 (1.0%)
Living place
Paris area 515 (52.2%)
Other region of metropolitan France 448 (45.4%)
French overseas departments 24 (2.4%)
No (%) of patients in risk group
Men who have sex with men 680 (68.9%)
Heterosexual 248 (25.1%)
Intravenous drug user 2 (0.2%)
Accidental exposure to infected blood 6 (0.6%)
Other 51 (5.2%)
Median CD4 cell count (cells/mm3) (range) 508 (22–1509)
Median HIV RNA (log10 copies/ml) (range) 5.11 (1.48–8.8)
Serological syphilis testing
Isolated positive TPHA 116/877 (13.2%)
Isolated positive VDRL 63/885 (7.1%)
Positive TPHA and VDRL 57/871 (6.5%)
Serological HBV testing (n=914)
Positive HBs antigen 16 (1.8%)
Positive anti-HBc antibodies 238 (26.0%)
Isolated anti-HBs antibodies (vaccination) 360 (39.4%)
Positive serological HCV testing (n=932) 21 (2.3%)
TPHA=Treponema palladium haemagglutination assay; VDRL=Venereal
Diseases Research Laboratory test; HBV=hepatits B virus; HCV=hepatitis C
virus.
doi:10.1371/journal.pone.0031695.t001
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5 years over 1999–2003 to 12 years over 1998–2009) and routes of
HIV infection (0–28% of intravenous drugs users, 57–100% of
MSM) were different. It is difficult, thus, to extrapolate the results
from one study to another. Besides, these reports focused on
patients living in densely populated but quite restricted areas,
which could have facilitated the identification of clustered events
in the studied population. The setting is different in the PRIMO
cohort: participants are scattered throughout the French territory
and half of them are living outside the Paris area. Such
characteristics allowed us to underscore the role of recent HIV
infections in the spread of the viral epidemic at the national level;
this could also explain the lower frequency of clusters in our report
than in previous phylogenetic studies. A well known and
acknowledged limitation comes from the fact that many
individuals remain undiagnosed and unaware of their HIV status
in France [40]. Because patients not enrolled in the PRIMO
cohort may have been involved into clustered events, 12.7%
should be considered as a minimal estimation of the prevalence of
clusters among PHI in France.
Particular characteristics of patients involved into clusters events
have been evidenced in our study: gender, as shown in the Swiss
cohort [26], a homosexual preference, as previously described
[22], a younger age, as suggested in the Pao’s study [22] but not in
the Canadian and Swiss reports [24,26] and a high number of
casual sexual partnerships. These results underline behavioural
differences in HIV-risk sexual practices between men/women and
younger/older individuals. Interestingly, neither a history of STI
nor a positive syphilis serological test at enrolment was more
frequent in clustered events. However the frequency of these STI
was notably high in both groups of patients, suggesting a high
frequency of unprotected sex in the whole population: around one
in four patients declared having suffered from at least one STI and
near one in seven individuals had a positive syphilis serological
test. Moreover, half of these positive tests were probably due to an
active infection at the time of PHI (both positive TPHA and
VDRL tests).
In the PRIMO cohort, we found a significant increase in
clustered transmission in the recent years, involving 15.2% of the
enrolled patients in 2006–2010 versus 10.2% before. This result
Figure 1. Evolutionary relationships of the 125 HIV-1 reverse transcriptase genes involved into cluster transmissions. The
evolutionary history was inferred using the neighbour-joining method [35]. The optimal tree with the sum of branch length=1.69802916 is shown.
The tree is drawn to scale, with branch length in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The
evolutionary distances were computed using the Maximum Composite Likelihood method [37] and are in the units of the number of base
substitutions per site. Codon positions included were 1
st+2
nd+3
rd+noncoding. All positions containing gaps and missing data were eliminated from
the dataset. There were a total of 408 positions in the final dataset. Phylogenetic analyses were conducted in MEGA4 [38]. Viruses isolated in women
(#), male infected through heterosexual intercourse (&) and patients (all were men) infected through unknown intercourse (.) were represented.
doi:10.1371/journal.pone.0031695.g001
HIV-1 Transmission Dynamics in France
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31695could be explained by the failure to control the HIV epidemic in
the MSM population. Indeed, recent studies have highlighted the
high HIV incidence and the increasing number of new HIV
diagnoses in MSM in France as well as in several other
industrialised countries [41–43]. Several factors could explain this
evolution: an increase in unprotected anal sex and number of
sexual partners in MSM with and without HIV infection [44], an
increase in transmission of primary and secondary syphilis and
rectal lymphogranuloma venereum [45] and a high HIV
prevalence in the MSM population [41]. The increasing frequency
of HIV-risk sexual practices in MSM may have led to raise the
frequency of clustered events.
We found a relatively low (11.7%) proportion of transmitted-
drug resistant (TDR) variants. Furthermore, although transmission
of multi-drug resistant (MDR) strains has been evidenced in the
PRIMO cohort [46], no MDR viruses were involved in clustered
transmissions. Different results were reported on the frequency of
TDR in clustered infections. Yerly et al. have recently described in
newly diagnosed HIV infections that clusters were more frequent
in individuals with resistant variants than in those with sensitive
strains; they concluded that newly diagnosed, untreated individ-
uals were a significant source of onward transmission, particularly
of resistant viruses, thus suggesting an important self-fueling
mechanism for TDR [26]. In contrast, other reports have
described a lower prevalence of TDR in clusters as compared
with unique PHI, suggesting a reduced transmissibility of drug-
resistant strains, and in particular of MDR variants [23,24]. To
sum up, there is no evidence of greater or lower transmissibility of
resistant variants. However, in population with high rates of TDR
and/or frequent HIV-risk behaviour leading to high proportion of
clustered events, clusters could contribute to the spread of resistant
strains in the population.
We found that the maximal period of time between the first and
the latest PHI within the same cluster was #6months and #24
months in 27.2% and 68.8% of the clusters,, respectively. These
results are in keeping with previous phylogenetic studies, showing
that the majority of transmission events occurred within the 2
years following PHI [24–27], but only part of them could be
Table 2. Comparison of the characteristics of patients included into clustered transmission versus non-clustered: the ANRS PRIMO
cohort 1999–2010.
Characteristics Clustered transmissions (n=125) Nonclustered unique PHI (n=862) p
Male 118 94.4% 716 83% 0.001
Median age (years) (range) 33 19–64 35 17–79 0.01
Caucasian ethnicity 112 89.6% 731 84.8% 0.16
Living place in Paris area 61 48.8% 454 52.7% 0.42
Risk group: MSM 103 87.3% 577 80.6% 0.08
Viral subtype B 106 84.8% 614 71.2% 0.001
Viral resistance
$1 class of antiretrovirals 20 16% 96 11.1% 0.11
$2 classes of antiretrovirals 0 0 24 2.8% 0.06
Median CD4 cell count (cells/mm3) (range) 504 62–1265 509 22–1509 0.61
Median HIV RNA (log10 copies/ml) (range) 5.13 2.2–7.41 5.11 1.48–8.08 0.36
Year of inclusion
2006–2010 73 58.4% 406 47.1% 0.02
Serological syphilis testing at baseline
Isolated positive TPHA 14 12.4% 102 13.4% 0.78
Both positive TPHA and VDRL 7 6.2% 50 6.6% 0.89
Prior sexually transmitted infections
(1) 31 26.3% 196 24.1% 0.6
Median number of previous negative HIV serological tests (range) 5 0–30 3 0–72 0.14
Frequency of previous HIV screening
.1 test/year 53 61.6% 279 52.7% 0.13
Number of regular sexual partnerships
(2)
0–1 80 77.7% 506 78.2%
2 8 7.8% 68 10.5% 0.48
.2 15 14.6% 73 11.3%
Number of casual sexual partnerships
(2)
0–1 28 28.3% 291 45.4%
2–10 45 45.5% 205 31.9% 0.004
.10 26 26.3% 147 22.9%
Note: the total of patients for each variable does not always equal the total sample due to some missing values. PHI=primary HIV infection; MSM=men having sex with
men; TPHA=Treponema palladium haemagglutination assay; VDRL=Venereal Diseases Research Laboratory test.
(1)Urethritis, rectitis, genital herpes infection, vulvo-vaginal candidosis, condyloma and/or syphilis.
(2)In the last 6 months preceding PHI diagnosis.
doi:10.1371/journal.pone.0031695.t002
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Although all patients of the cohort have been enrolled at the time
of PHI, most of them contracted the virus from chronically
infected patients and the role of ‘‘recent chronic’’ (but not
necessarily primary) infections has increased in the recent years.
This finding is important to design effective preventive strategies in
order to reduce HIV transmission, especially to assess the potential
benefit for public health of an early antiretroviral therapy. A
recent Swiss report showed lower viral transmission rates in HIV-
infected MSM who received an ART since the time of PHI [50].
However, the long period of time (.2 years) between the first and
latest patients within the same cluster in more than 30% of the
cases, may suggest the need for a, not only early, but also
prolonged ART to reduce the risks of HIV spread in the
population. Interestingly, the proportion of early-treated patients
fell from 88% in 1996–1997 to 29% in 2006–2007 in our cohort
(Troude P, AIDS 2009) and we can not exclude a possible causal
link between this evolution and the recent increasing frequency of
clustered transmissions. Of note, French guidelines do not
recommend the discontinuation of a combined ART initiated at
the time of PHI [51].
In our study, more than 75% of the clustered transmissions
chains had 2 infections per cluster. Unlike the results by Brenner
et al [24,27], the proportion of large clusters ($4 PHI) was
significantly lower in our study (1.8% of all PHI). As previously
discussed, the geographical proximity of the participants enrolled
in the Quebec studies, including mainly MSM living in Montreal
area, may have increased the risk that many people are infected by
the same strain. We also analysed differences among patients
involved into small and large clusters. Although the small number
of large clusters limited the possibilities of finding statistically
significant differences, we did evidenced some specific features.
Large clusters involved exclusively MSM; they tended to be
younger and to have a higher number of declared sexual partners,
and a higher number of previous HIV tests. Interestingly, the
proportion of positive syphilis serological tests was lower in large
versus small clusters. These findings may be explained by one
behavioural assumption, which has been recently evoked in the
Montreal MSM epidemic: Brenner et al. concluded that MSM in
small clusters engaged in higher HIV risk contacts but with fewer
partners than those involved into large clusters [27]. Conversely,
patients involved into large clusters may be engaged with a great
number of sexual partnerships, perhaps in meeting places for sex
with multiple partners, but highly informed about screening,
condoms and information about HIV transmission. This could
explain the low prevalence of positive syphilis serology and the
Table 3. Comparison between the characteristics of the patients included into small (2–3 patients/cluster) or large (.4 patients/
clusters) clustered events.
Characteristics Large clusters ($4 PHI) (n=18) Small clusters(2–3 PHI) (n=107) p
Size of the clusters (months) (range) 19.3 10–53 12.0 0–85.5 0.33
Male 18 100% 100 93.5% 0.59
Median age (years) (range) 32 24–44 35 19–64 0.13
Caucasian ethnicity 17 94.4% 95 88.8% 0.69
Living place in Paris area 11 61.1% 50 46.7% 0.26
Risk group: MSM 18 100% 85 85% 0.12
Viral subtype B 13 72.2% 93 86.9% 0.15
Viral resistance $1 class of antiretrovirals 0 0 20 18.7% 0.07
Median CD4 cell count (cells/mm3) (range) 570 128–843 479 62–1265 0.92
Median HIV RNA (log10 copies/ml) (range) 4.99 2.93–6.67 5.14 2.2–7.41 0.58
Year of inclusion
2006–2010 13 72.2% 60 56.1% 0.20
Serological syphilis testing at baseline
Isolated positive TPHA 1 5.9% 13 13.5% 0.69
Both positive TPHA and VDRL 0 0 7 7.3% 0.59
Past sexually transmitted infections
(1) 5 29.4% 26 25.7% 0.77
Median number of previous negative HIV serological tests (range) 7 1–30 3.5 0–25 0.01
Frequency of previous HIV screening
#1 test/year 9 56.3% 48 68.6% 0.35
Number of regular sexual partnerships
(2)
0–2 10 62.5% 70 80.5% 0.19
.2 6 37.5% 17 19.5%
Number of casual sexual partnerships
(2)
0–1 3 18.8% 25 30.1% 0.55
$2 13 81.3% 58 69.9%
Note: the total of patients for each variable does not always equal the total sample due to some missing values.
(1)Urethritis, rectitis, genital herpes infection, vulvovaginal candidosis, condyloma and/or syphilis.
(2)In the last 6 months preceding PHI diagnosis.
doi:10.1371/journal.pone.0031695.t003
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is confirmed in further behavioural studies, it could have a major
impact in understanding the different dynamic transmission
profiles to be addressed for specifically targeted prevention and/
or antiretroviral treatment interventions.
To conclude, we show evidence that 12.7% of patients
diagnosed at the time of PHI were involved into clustered
transmissions in France. Given than many individuals remain
undiagnosed and unaware of their HIV status in France, this
12.7% rate should be considered as a minimal estimation of the
frequency of clustered transmissions in France. Such transmission
events, whose frequency increased in the most recent years, have a
significant impact on the spread of the HIV epidemic, with a
specially high transmission risk during the 2 years following
infection. Our findings may suggest that starting antiretroviral
therapy at the time of PHI may limit HIV transmission, especially
in young MSM with high number of sexual partnerships, who are
usually involved into large clustered events. Moreover, clusters
have the potential to contribute to the spread of resistant strains.
Our study underscores recommendations for genotyping in
primary infection to document clustering of infection and provide
information on transmitted drug resistance and behavioural
characteristics of infected people.
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